Mitotix Overview

  • Year Founded
  • 1992

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

Mitotix General Information

Description

Developer of therapeutic products for the treatment of diseases resulting from inappropriate cell proliferation. The company's approach is based the mechanisms that regulate the cell division cycle, the process by which cells grow, each replicating into two daughter cells. It treats cancer based on their underlying molecular defects like mutation in the cell cycle regulatory genes.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • One Kendall Square
  • Cambridge, MA 02139
  • United States
+1 (617)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • One Kendall Square
  • Cambridge, MA 02139
  • United States
+1 (617)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Mitotix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 01-Mar-2000 Completed Product Development
2. Early Stage VC 16-Feb-1996 Completed Product Development
1. Early Stage VC 10-Jul-1994 $12.3M $12.3M Completed Product Development
To view Mitotix’s complete valuation and funding history, request access »

Mitotix Patents

Mitotix Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-1993024514-A1 D-type cyclin and uses related thereto Inactive 26-May-1992

Mitotix Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Advent International PE/Buyout Minority
CIT Bank Lender/Debt Provider Minority
Greylock Venture Capital Minority
Highland Capital Partners Venture Capital Minority
North Bridge Venture Partners Venture Capital Minority
To view Mitotix’s complete investors history, request access »

Mitotix FAQs

  • When was Mitotix founded?

    Mitotix was founded in 1992.

  • Where is Mitotix headquartered?

    Mitotix is headquartered in Cambridge, MA.

  • What industry is Mitotix in?

    Mitotix’s primary industry is Drug Discovery.

  • Is Mitotix a private or public company?

    Mitotix is a Private company.

  • What is Mitotix’s current revenue?

    The current revenue for Mitotix is .

  • How much funding has Mitotix raised over time?

    Mitotix has raised $25.4M.

  • Who are Mitotix’s investors?

    Advent International, CIT Bank, Greylock, Highland Capital Partners, and North Bridge Venture Partners have invested in Mitotix.

  • When was Mitotix acquired?

    Mitotix was acquired on 01-Mar-2000.

  • Who acquired Mitotix?

    Mitotix was acquired by GPC Biotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process